LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Monte Rosa Therapeutics (NASDAQ: GLUE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ GLUE Monte Rosa Therapeutics
Behbahani Ali / director, 10 percent owner:
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Hughes Eric A / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Manning Anthony M. / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Blackwell Kimberly / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Siu Christine / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Skvarka Jan / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
SCHIFF ANDREW N / director
06/13/2025
Buy
$4.91
30,700
$151K
30,700
NASDAQ GLUE Monte Rosa Therapeutics
Dunn Edmund / officer: Principal Accounting Officer
06/03/2025
Sell
$4.45
2,062
$9K
23,732